Stay updated on DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial

Sign up to get notified when there's something new on the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added a new MedlinePlus Genetics topic: Multiple myeloma.
    Difference
    0.2%
    Check dated 2025-10-19T16:57:46.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Removed a MedlinePlus Genetics topic on Multiple myeloma, reducing coverage of that condition in the Genetics section.
    Difference
    0.2%
    Check dated 2025-10-12T15:49:26.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Summary: The page now announces a government funding lapse with current operating status guidance and upgrades the version from v3.1.0 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-05T12:51:26.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Core terminology updated from 'Plasma cell myeloma' to 'Multiple myeloma' and the page version bumped to v3.1.0.
    Difference
    0.2%
    Check dated 2025-09-28T09:32:30.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Added a MedlinePlus Genetics topic on multiple myeloma, expanding core content with genetics-related information about the disease.
    Difference
    0.2%
    Check dated 2025-09-21T06:29:12.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    - Update: revision changed from v3.0.1 to v3.0.2; the 'Back to Top' element was removed. No changes to core content, pricing, stock availability, or time-slot information.
    Difference
    0.2%
    Check dated 2025-09-13T23:58:12.000Z thumbnail image

Stay in the know with updates to DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page.